Telmisartan Tablets — Class III drug recall D-0824-2016
Terminated recall by Torrent Pharmaceuticals Limited, reported 2016-04-27, distributed nationwide. Presence of Foreign Substance: Product complaint for the presence of foreign matter identified as silicone wit
| Recall number | D-0824-2016 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Torrent Pharmaceuticals Limited, Kadi, N/A, India |
| Recall initiated | 2016-02-25 |
| Classified | 2016-04-18 |
| Reported by FDA | 2016-04-27 |
| Terminated | 2016-06-03 |
| Distributed | Nationwide (US) |
| Quantity | 20,952 cartons |
| Reason classes | foreign material |
| NDC | 13668-0158-72 |
| Lot numbers | 12/16, BBV8B002R |
Product
Telmisartan Tablets, USP, 80 mg, 30-count (3 x 10 unit-dose blisters) per carton, Rx only, Manufactured by: Torrent Pharmaceuticals LTD., Indrad-382 721, Dist. Mehsana, INDIA.; For: Torrent Pharma Inc., 150 Allen Road, Suite 102, Basking Ridge, NJ 07920, NDC 13668-158-72, UPC 3 13668 158 72 4.
Reason for recall
Presence of Foreign Substance: Product complaint for the presence of foreign matter identified as silicone within the tablet.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0824-2016. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.